Nephrogenic systemic fibrosis, gadolinium, and iron mobilization [17]

New England Journal of Medicine

Volumn 357, Issue 7, 2007, Pages 720-722

  Swaminathan, Sundararaman ^a   Horn, Thomas D ^a   Pellowski, Donna ^a   Abul Ezz, Sameh ^a   Bornhorst, Joshua A ^a   Viswamitra, Sanjaya ^a   Shah, Sudhir V ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADODIAMIDE; GADOLINIUM; IRON; TRANSFERRIN;

ADULT; AGED; CLINICAL ARTICLE; DISEASE PREDISPOSITION; FEMALE; FIBROSIS; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IRON KINETICS; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY INJURY; LETTER; LIVER FUNCTION TEST; MALE; NEPHROGENIC SYSTEMIC FIBROSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC DISEASE;

EID: 34547947401     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc070248     Document Type: Letter

References (5)

1. Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 2000;356:1000-1.
2. Swaminathan S, Ahmed I, McCarthy JT, et al. Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy. Ann Intern Med 2006;145:234-5.
3. Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006;21:1104-8. [Erratum, Nephrol Dial Tranplant 2006;21:1745.]
4. High WA, Ayers RA, Chandler J, Zito G, Cowper SE. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 2007;56:21-6.
5. Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990;186:1-85.